
Professor Sir Mike Stratton, FMedSci FRS
Senior Group Leader
Mike Stratton is a Senior Group Leader in the Cancer, Ageing and Somatic Mutation Programme. His primary research interests have been in the genetics of cancer. His early research focused on inherited susceptibility. Mike mapped and identified the major high-risk breast cancer susceptibility gene BRCA2 and subsequently a series of moderate-risk breast cancer and other cancer susceptibility genes.
In 2000 Mike initiated the Cancer Genome Project at the Wellcome Sanger Institute which conducts systematic genome-wide searches for somatic mutations in human cancer. Through these studies he discovered somatic mutations of the BRAF gene in malignant melanoma and several other mutated cancer genes in lung, renal, breast and other cancers. He has described the basic patterns of somatic mutation in cancer genomes revealing underlying DNA mutational and repair processes.
Mike is a Fellow of the Royal Society (FRS) and was Knighted by the Queen in 2013.
My timeline
The 2016 Mike Price Gold Medal Award, European Association of Cancer Research
The ESHG Award, European Society of Human Genetics
Fellow of the AACR Academy
The AACR Distinguished Lecturer in Breast Cancer Research Award
The Ernst W Bertner Award, MD Anderson Cancer Centre
The Sergio Lombroso Award in Cancer Research, Weizmann Institute
The GHA Clowes Award, American Association of Cancer Research, USA
The Louis-Jeantet Prize for Medicine
Knighted in the Queen's Birthday Honours List
Royal Physiographical Society Medal, Lund, Sweden
Estella Medrano Memorial Lecture Award, Society for Melanoma Research
Appointed Chief Executive Officer of the Wellcome Genome Campus.
The Massachusetts General Hospital Award in Cancer Research
The Lila Gruber Award for Cancer Research, American Academy of Dermatology
Appointed as the Director of the Sanger Institute
Member of EMBO
The C. Chester Stock Award, Memorial Sloan Kettering Cancer Centre
Member of the European Molecular Biology Organisation
Fellow of the Royal Society
The BioMedicum Helsinki Medal, Finland
The AstraZeneca Award, Biochemical Society
Appointed as Deputy Director of the Sanger Institute
The Lennox K Black Award for Excellence in Medicine, Thomas Jefferson University
The Tom Connors Award, British Association of Cancer Research
Member of the Sanger Institute's Board of Management
Initiated the Cancer Genome Project and became the Head of this Programme
Fellow of the Academy of Medical Sciences
Appointed as Professor of Cancer Genetics and Chair of the newly constitute section of Cancer Genetics at the Institute of Cancer Research
Reader in the Molecular Genetics of Cancer, Institute of Cancer Research
Honorary Consultant, Royal Marsden Hospital
Team Leader in Molecular Carcinogenesis at the Institute of Cancer Research
Obtained the MRCPath and qualified as a Consultant Pathologist - Hammersmith and Maudsley Hospital
Senior Registrar, Department of Neuropathology, Institute of Psychiatry
Conducted research for a PhD on the molecular biology of cancer at the Institute Cancer Research
MRC Training Fellow, Institute of Cancer Research and Institute of Psychiatry
Trained as a histopathologist
Senior House Office - Pathology - Westminster Hospital
Research Fellow, Institute of Psychiatry
House Physician at Beckenham Hospital
House Surgeon at Guys Hospital
Qualified in medicine at Oxford